Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Filip Krag Knop

Filip Krag Knop

Chief Consultant

Niels Steensens Vej 2-4

2820 Gentofte

Denmark

​Gentofte Hospital

Building: Opgang ​7, 3. sal, Kildegårdsvej 28

2900 Hellerup

Denmark

  1. 2010
  2. Published

    Inappropriate glucagon response after oral compared with isoglycemic intravenous glucose administration in patients with type 1 diabetes

    Hare, K. J., Vilsbøll, T., Holst, J. J. & Knop, F. K., 1 Apr 2010, In : American Journal of Physiology: Endocrinology and Metabolism. 298, 4, p. E832-7

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Once-weekly GLP-1 agonists: How do they differ from exenatide and liraglutide?

    Christensen, M. & Knop, F. K., 1 Apr 2010, In : Current Diabetes Reports. 10, 2, p. 124-32 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published
  5. Published

    Increased postprandial response of glucagon-like peptide-2 in patients with chronic pancreatitis and pancreatic exocrine insufficiency

    Hornum, M., Pedersen, J., Larsen, S., Olsen, O., Holst, J. J. & Knop, F. K., 1 Jan 2010, In : Pancreatology. 10, 2-3, p. 201-7 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes - a review

    Hansen, K. B., Vilsbøll, T. & Knop, F. K., 1 Jan 2010, In : Diabetes, Metabolic Syndrome and Obesity. 3, p. 155-63 9 p.

    Research output: Contribution to journalReviewResearchpeer-review

  7. Published

    Incretin-based therapy and type 2 diabetes

    Hare, K. J. & Knop, F. K., 1 Jan 2010, In : Vitamins and Hormones. 84, p. 389-413 25 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published
  9. 2009
  10. Published

    Preserved inhibitory potency of GLP-1 on glucagon secretion in type 2 diabetes mellitus

    Hare, K. J., Knop, F. K., Asmar, M., Madsbad, S., Deacon, C. F., Holst, J. J. & Vilsbøll, T., 1 Dec 2009, In : The Journal of clinical endocrinology and metabolism. 94, 12, p. 4679-87 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Resolution of type 2 diabetes following gastric bypass surgery: involvement of gut-derived glucagon and glucagonotropic signalling?

    Knop, F. K., 1 Nov 2009, In : Diabetologia. 52, 11, p. 2270-6 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Lixisenatide, a novel GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus

    Christensen, M., Knop, F. K., Holst, J. J. & Vilsbøll, T., 1 Aug 2009, In : IDrugs : the investigational drugs journal. 12, 8, p. 503-13 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. Published

    The spectrum of antidiabetic actions of GLP-1 in patients with diabetes

    Vilsbøll, T., Holst, J. J. & Knop, F. K., 1 Aug 2009, In : Best Practice & Research: Clinical Endocrinology & Metabolism. 23, 4, p. 453-62 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  14. Published

    Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes

    Højberg, P. V., Vilsbøll, T., Rabøl, R., Knop, F. K., Bache, M., Krarup, T., Holst, J. M. & Madsbad, S., 1 Feb 2009, In : Diabetologia. 52, 2, p. 199-207 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  15. Published

    Incretin-based therapy of type 2 diabetes mellitus

    Knop, F. K., Vilsbøll, T. & Holst, J. J., 1 Feb 2009, In : Current Protein and Peptide Science. 10, 1, p. 46-55 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  16. Published

    KATP channel closure ameliorates the impaired insulinotropic effect of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes

    Aaboe, K., Knop, F. K., Vilsbøll, T., Vølund, A., Simonsen, U., Deacon, C. F., Madsbad, S., Holst, J. J. & Krarup, T., 1 Feb 2009, In : Journal of Clinical Endocrinology and Metabolism. 94, 2, p. 603-8 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  17. Published

    Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists

    Hansen, K. B., Knop, F. K., Holst, J. J., Vilsbøll, T. & Holst, J. J., 2009, In : International Journal of Clinical Practice. 63, 8, p. 1154-60 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  18. 2008
  19. Published

    Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetes

    Højberg, P. V., Vilsbøll, T., Zander, P-O. M., Knop, F. K., Krarup, T., Vølund, A., Holst, J. M. & Madsbad, S., 1 Nov 2008, In : Diabetic Medicine. 25, 11, p. 1268-75 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  20. Published

    Replacing SUs with incretin-based therapies for type 2 diabetes mellitus: challenges and feasibility

    Knop, F. K., Holst, J. J. & Vilsbøll, T., 1 Jul 2008, In : I Drugs: the Investigational Drugs Journal. 11, 7, p. 497-501 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  21. Published

    Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes

    Højberg, P. V., Zander, P-O. M., Vilsbøll, T., Knop, F. K., Krarup, T., Vølund, A., Holst, J. M. & Madsbad, S., 1 Apr 2008, In : Diabetologia. 51, 4, p. 632-40 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  22. Published

    Long-acting GLP-1 analogs for the treatment of type 2 diabetes mellitus

    Vilsbøll, T. & Knop, F. K., 1 Jan 2008, In : BioDrugs. 22, 4, p. 251-7 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  23. 2007
  24. Published
  25. Published

    Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state?

    Knop, F. K., Vilsbøll, T., Højberg, P. V., Larsen, S., Madsbad, S., Vølund, A., Holst, J. J. & Krarup, T., 1 Aug 2007, In : Diabetes. 56, 8, p. 1951-9 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  26. Published

    Betydningen af inkretinhormonerne glucose-dependent insulinotropic peptide og glucagon-like peptide-1 for patogenesen ved type 2-diabetes mellitus

    Vilsbøll, T. & Knop, F. K., 28 May 2007, In : Ugeskrift for Laeger. 169, 22, p. 2101-5 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  27. Published

    Glucagon-like peptide 1-baseret behandling af type 2-diabetes mellitus

    Knop, F. K. & Vilsbøll, T., 28 May 2007, In : Ugeskrift for Laeger. 169, 22, p. 2095-9 5 p.

    Research output: Contribution to journalReviewResearchpeer-review

  28. Published

    Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus

    Knop, F. K., Vilsbøll, T., Madsbad, S., Holst, J. M. & Krarup, T., 1 Apr 2007, In : Diabetologia. 50, 4, p. 797-805 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  29. Published
  30. 2006
  31. Published

    Vaerdien af billeddiagnostiske undersøgelser ordineret i almen praksis

    Knop, F. K. & Stauning, J. A., 20 Feb 2006, In : Ugeskrift for Laeger. 168, 8, p. 794-8 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  32. 2005
  33. Published

    The Nkx6.1 homeodomain transcription factor suppresses glucagon expression and regulates glucose-stimulated insulin secretion in islet beta cells

    Schisler, J. C., Jensen, P. B., Harper, D. A. T., Becker, T., Knop, F. K., Takekawa, S., German, M., Weir, G. C., Lu, D., Mirmira, R. G. & Newgard, C. B., 17 May 2005, In : Proceedings of the National Academy of Sciences of the United States of America. 102, 20, p. 7297-302 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  34. 2004
  35. Published
  36. Published

    Self-expanding metal stents for colonic obstruction: experiences from 104 procedures in a single center

    Meisner, S., Hensler, M., Knop, F. K., West, F. & Wille-Jørgensen, P., 1 Apr 2004, In : Diseases of the Colon and Rectum. 47, 4, p. 444-50 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  37. 2003
  38. Published

    The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype

    Vilsbøll, T., Knop, F. K., Krarup, T., Johansen, A., Madsbad, S., Larsen, S., Hansen, T., Pedersen, O. & Holst, J. M., 1 Oct 2003, In : Journal of Clinical Endocrinology and Metabolism. 88, 10, p. 4897-903 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  39. Published
  40. Published

    Small-bowel hemangiosarcoma and capsule endoscopy

    Knop, F. K., Hansen, M. B. & Meisner, S., 1 Jul 2003, In : Endoscopy. 35, 7, p. 637

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1...3 4 5 6 7 Next

ID: 31007257